Molecular Targets in Hepatocarcinogenesis and Implications for Therapy
AbstractHepatocarcinogenesis comprises of multiple, complex steps that occur after liver injury and usually involve several pathways, including telomere dysfunction, cell cycle, WNT/β-catenin signaling, oxidative stress and mitochondria dysfunction, autophagy, apoptosis, and AKT/mTOR signaling. Following liver injury, gene mutations, accumulation of oxidative stress, and local inflammation lead to cell proliferation, differentiation, apoptosis, and necrosis. The persistence of this vicious cycle in turn leads to further gene mutation and dysregulation of pro- and anti-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, IL-10, IL-12, IL-13, IL-18, and transforming growth factor (TGF)-β, resulting in immune escape by means of the NF-κB and inflammasome signaling pathways. In this review, we summarize studies focusing on the roles of hepatocarcinogenesis and the immune system in liver cancer. In addition, we furnish an overview of recent basic and clinical studies to provide a strong foundation to develop novel anti-carcinogenesis targets for further treatment interventions. View Full-Text
Share & Cite This Article
Wu, M.-Y.; Yiang, G.-T.; Cheng, P.-W.; Chu, P.-Y.; Li, C.-J. Molecular Targets in Hepatocarcinogenesis and Implications for Therapy. J. Clin. Med. 2018, 7, 213.
Wu M-Y, Yiang G-T, Cheng P-W, Chu P-Y, Li C-J. Molecular Targets in Hepatocarcinogenesis and Implications for Therapy. Journal of Clinical Medicine. 2018; 7(8):213.Chicago/Turabian Style
Wu, Meng-Yu; Yiang, Giuo-Teng; Cheng, Pei-Wen; Chu, Pei-Yi; Li, Chia-Jung. 2018. "Molecular Targets in Hepatocarcinogenesis and Implications for Therapy." J. Clin. Med. 7, no. 8: 213.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.